Pérez-Lamas, Lucía; Manzanares, Mario; Hernández-Boluda, Juan-Carlos; Casado-Montero, Luis-Felipe; Gómez-Casares, María-Teresa; Ayala, Rosa; Xicoy, Blanca; Ferrer-Marín, Francisca; Orti, Guillermo; De-Paz-Arias, Raquel; Osorio-Prendes, Santiago; Pérez-López, Raúl; Mora, Elvira; Ruiz-Nuno, Concepción; Jiménez-Velasco, Antonio; Boque, Concepción; Sierra-Pacho, Magdalena; Martínez-López, Joaquín; Carreño-Tarragona, Gonzalo; Coiras, Mayte; García-Gutiérrez, Valentín
(SPRINGERNATURE, 2026-01-20)
Tyrosine kinase inhibitors (TKIs) discontinuation is the standard option for patients with chronic myeloid leukaemia (CML) in deep molecular response (MR) with imatinib. This study aimed to evaluate the efficacy and safety ...